Surgical Drapes Market By Type (Reusable, Disposable), By Risk Type (Moderate (AAMI Level 3), High (AAMI Level 4), Others), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

The global surgical drapes market was valued at $1.5 billion in 2022, and is projected to reach $2.1 billion by 2032, growing at a CAGR of 3.6% from 2023 to 2032. Surgical drapes are sterile and protective barriers used in medical and surgical settings to maintain aseptic conditions during procedures. These drapes are typically made from woven and non-woven materials, such as polypropylene, cotton and polyester, and are designed to prevent the transfer of microorganisms between the patient's skin and the surgical team, as well as to create a clean, controlled environment around the surgical site. Surgical drapes are available in various shapes and sizes to accommodate different procedures, ensuring that only the necessary area is exposed while the rest remains covered. They feature adhesive or fenestrations to provide access to the specific area requiring treatment. These drapes are essential in preventing surgical site infections by minimizing the risk of contamination, controlling fluid runoff, and maintaining a sterile field, which is crucial for successful surgical outcomes and patient safety.

The increase in number of surgeries and surge in hospital-acquired infections (HAIs) are major drivers of the surgical drapes market. HAIs are the leading cause of morbidity and mortality in hospitalized patients. For instance, the report of World Health Organization (WHO) 2021, stated that, up to 30% of patients are affected by at least one hospital acquired infections (HAIs) in intensive care units. This alarming prevalence underscores the need for stringent infection control measures, including the use of surgical drapes, to create and maintain sterile environments in healthcare settings.

Moreover, both non-governmental and government organizations are spearheading initiatives aimed at increasing awareness of infection control measures by conduct programs and campaigns to educate patients and healthcare facilities. Thus, increased awareness, combined with the surge in adoption of infection prevention and control guidelines that recommend the use of surgical drapes, is anticipated to further fuel the market growth. These factors collectively highlight the pivotal role of surgical drapes in mitigating infection risks and enhancing patient safety.

Moreover, the market for surgical drapes is benefiting from a growing emphasis on environmental sustainability. The move towards reducing the environmental impact of plastic drapes is a significant driver propelling the growth. Various stakeholders, including government organizations, industry leaders, and healthcare facilities, are actively endorsing sustainability initiatives. This involves promoting the use of eco-friendly materials in drape manufacturing and encouraging responsible disposal practices, aligning with global efforts to make healthcare more environmentally conscious and eco-friendly. For instance, companies like Molnlycke Health Care are taking proactive steps, enhancing manufacturing processes, such as BARRIER Universal ISCC, to reduce fossil-based CO2 emissions and promote sustainability throughout the supply chain. This trend aligns with the broader global movement towards environmentally conscious healthcare solutions and thus drive the market growth.

In addition, the key players are adopting strategic initiatives to foster growth, including expansion and product launches. For instance, in March 2022, Cardinal Health, a global manufacturer and distributor of medical and laboratory products announced the launch of the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate (CHG). Such innovative product launches and expansions are expected to be propelling market growth, as they address the evolving needs of healthcare professionals and enhance infection control measures, ultimately contributing to improved patient outcomes.

The surgical drapes market is segmented into type, risk type, end user and region. On the basis of type, the market is categorized into reusable and disposable. On the basis of risk type, the market is categorized into moderate (AAMI Level 3), high (AAMI Level 4) and others. On the basis of end user, the market is segregated into hospitals, ambulatory surgical centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global surgical drapes market include Molnlycke Health Care AB, Narang Medical Limited, Cardinal Health, Medline Industries Inc, Medica Europe BV, Priontex, Delta Med SpA Paul Hartmann AG, 3M Company and Standard Textile Co., Inc. The key players have adapted product launch as the strategies to enhance its product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical drapes market analysis from 2022 to 2032 to identify the prevailing surgical drapes market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the surgical drapes market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global surgical drapes market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Technology Trend Analysis
Patient/epidemiology data at country, region, global level
Regulatory Guidelines
Additional company profiles with specific to client's interest
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Type

Reusable
Disposable

By Risk Type

Others
Moderate (AAMI Level 3)
High (AAMI Level 4)

By End User

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Narang Medical Limited
Delta Med SpA
Cardinal Health
Molnlycke Health Care AB
Priontex
Paul Hartmann AG
3M Company
Medica Europe BV
Standard Textile Co., Inc.
Medline Industries Inc.

Product Code: A03454

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. High bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Surge in number of surgeries
  - 3.4.1.2. Technological advancements in surgical drapes
  - 3.4.1.3. Growth in government initiatives for infection prevention and control
- 3.4.2. Restraints
  - 3.4.2.1. Competition among the key players
  - 3.4.2.2. Product recalls
- 3.4.3. Opportunities
  - 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: SURGICAL DRAPES MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Reusable
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Disposable
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: SURGICAL DRAPES MARKET, BY RISK TYPE

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Moderate (AAMI Level 3)
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. High (AAMI Level 4)
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: SURGICAL DRAPES MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: SURGICAL DRAPES MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Risk Type
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Type
  - 7.2.5.1.2. Market size and forecast, by Risk Type
  - 7.2.5.1.3. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Type
  - 7.2.5.2.2. Market size and forecast, by Risk Type
  - 7.2.5.2.3. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Type
  - 7.2.5.3.2. Market size and forecast, by Risk Type
  - 7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Risk Type
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Type
  - 7.3.5.1.2. Market size and forecast, by Risk Type
  - 7.3.5.1.3. Market size and forecast, by End User
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Type
  - 7.3.5.2.2. Market size and forecast, by Risk Type
  - 7.3.5.2.3. Market size and forecast, by End User
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Type
  - 7.3.5.3.2. Market size and forecast, by Risk Type
  - 7.3.5.3.3. Market size and forecast, by End User
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Type
  - 7.3.5.4.2. Market size and forecast, by Risk Type
  - 7.3.5.4.3. Market size and forecast, by End User
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Type
  - 7.3.5.5.2. Market size and forecast, by Risk Type
  - 7.3.5.5.3. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Type
  - 7.3.5.6.2. Market size and forecast, by Risk Type
  - 7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Risk Type
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Type
  - 7.4.5.1.2. Market size and forecast, by Risk Type
  - 7.4.5.1.3. Market size and forecast, by End User
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Type
  - 7.4.5.2.2. Market size and forecast, by Risk Type
  - 7.4.5.2.3. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Type
  - 7.4.5.3.2. Market size and forecast, by Risk Type
  - 7.4.5.3.3. Market size and forecast, by End User
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Market size and forecast, by Type
  - 7.4.5.4.2. Market size and forecast, by Risk Type
  - 7.4.5.4.3. Market size and forecast, by End User
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Market size and forecast, by Type
  - 7.4.5.5.2. Market size and forecast, by Risk Type
  - 7.4.5.5.3. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Type
  - 7.4.5.6.2. Market size and forecast, by Risk Type
  - 7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Risk Type
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Type
  - 7.5.5.1.2. Market size and forecast, by Risk Type
  - 7.5.5.1.3. Market size and forecast, by End User
  - 7.5.5.2. South Africa,
  - 7.5.5.2.1. Market size and forecast, by Type
  - 7.5.5.2.2. Market size and forecast, by Risk Type
  - 7.5.5.2.3. Market size and forecast, by End User
  - 7.5.5.3. Saudi Arabia
  - 7.5.5.3.1. Market size and forecast, by Type
  - 7.5.5.3.2. Market size and forecast, by Risk Type
  - 7.5.5.3.3. Market size and forecast, by End User
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Market size and forecast, by Type
  - 7.5.5.4.2. Market size and forecast, by Risk Type
  - 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Molnlycke Health Care AB
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
9.2. Paul Hartmann AG
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
9.3. Narang Medical Limited
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
9.4. Standard Textile Co., Inc.
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
9.5. Delta Med SpA
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
9.6. Medline Industries Inc.
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
9.7. Priontex
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
9.8. Medica Europe BV
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
9.9. Cardinal Health
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
9.10. 3M Company
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance